Merck & Co., Inc. (MRK) vs Oracle Corporation (ORCL)

Merck & Co., Inc. develops pharmaceutical products across multiple therapeutic areas, including cardiometabolic disorders, oncology, and infectious diseases. In cancer treatment, its immuno-oncology portfolio, led by Keytruda, represents a significant driver of total revenue. The company also maintains a strong vaccines business focused on preventing pediatric illnesses, alongside Gardasil for human papillomavirus. In addition, Merck markets animal health products. Geographically, 47% of the company’s sales come from its U.S. human health segment, which includes pharmaceuticals and vaccines.

Oracle Corporation delivers enterprise applications and infrastructure solutions through flexible IT deployment models, including on-premises, cloud, and hybrid environments. Founded in 1977, Oracle introduced the first commercial SQL-based relational database management system, widely used by many of the world’s largest enterprises for high-volume online transaction processing. In addition to its database products, Oracle offers enterprise resource planning platforms and cloud infrastructure that are becoming increasingly important for large language model training and inference.